NEW YORK — A retrospective study of more than 36,000 patients showed that geographic atrophy causes substantial disease burden, according to a speaker here.
“Longer-term outcomes regarding the progression of geographic atrophy for patients with macular degeneration are generally lacking,” Ehsan Rahimy, MD, said at the American Society of Retina Specialists annual meeting.
Rahimy and colleagues analyzed data from 36,817 patients with geographic atrophy who had 3 or more years of follow-up and excluded patients with active or a history of choroidal neovascularization, adults